The Registration Board in its 261st meeting held on 28th July 2016 warned the companies, manufacturers / importers for disruption in supplies / shortages of life saving / essential medicines in the country off and on. The board discussed the matter in detail and valuated the situation that some of the essential and life-saving medicines, including anti-tuberculosis, drugs are in short supply / partial availability in the market. It was therefore, decided in the meeting that all the concerned manufacturers importers and the registration holders of such medicines be directed to submit current quarterly report for importation of drug substances, manufacturing report and sale record, to the Pharmaceutical Registration Division and Quality Assurance Division immediately, but not later than seven days. This should be the practice that within seven days at the end of each quarter the said report be submitted as directed. Board directed the firms to ensure the free availability of these life-saving and essential medicines in the market for the needy patients. DRAP & Ministry, with the support of Provincial Governments and Federal Agencies will initiate stern action against the defaulters, hoarders, black marketers or those spreading false information, aggravating the situation.